chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Visit Type:  Acute Visit CC:  poss shot reaction. History of Present Illness: Pt c/o poss reaction to Tdap recieved friday. States joint pn began in knees friday PM and has moved up the body, progressively getting worse. Pt c/o SOB, HA, N&V, and a general weakness.  Acute Visit History: The patient complains of headache and vomiting.  She denies cough, diarrhea, and fever.   Past Medical History: Reviewed history from 07/16/2008 and no changes required: MIGRAINE (ICD-346.90), FEMALE INFERTILITY (ICD-628.9), OBESITY (ICD-278.00), METABOLIC SYNDROME X (ICD-277.7), HYPERLIPIDEMIA (ICD-272.4), BACK PAIN (ICD-724.5), UTI (ICD-599.0)  Family History: Reviewed history from 05/14/2009 and no changes required: FH Alcoholism, FH Heart disease, other, FH Hyperlipidemia, FH Hypertension, RA - father, aunt and grandfather  Social History: Reviewed history from 04/28/2009 and no changes required: Married, Homemaker, 3 kids  Risk Factors:  Tobacco use:  never Passive smoke exposure:  yes Drug use:  no HIV high-risk behavior:  no Caffeine use:  0 drinks per day Alcohol use:  no Exercise:  yes    Times per week:  3    Type:  stationary bike Seatbelt use:  100 % Sun Exposure:  occasionally  Family History Risk Factors: Family History of MI in females < 65 years old:  no, Family History of MI in males < 55 years old:  yes  Vital Signs: Patient Profile: 37 Year Old Female Height: 65 inches (165.10 cm) Weight: 243.4 pounds (110.64 kg) BMI: 40.65 Temp: 98.6 degrees F (37.00 degrees C) oral Pulse rate: 76 / minute Pulse rhythm: regular BP sitting: 118 / 78  (left arm) Cuff size: large  Physical Exam General: appears ill but non-toxic.   Ears: TM's and ear canals normal;  Nose: nasal mucosa normal;  Mouth: mouth and throat clear;  Neck: no masses or abnormal cervical nodes;  Lungs: breathing non-labored, clear to auscultation bilaterally;  Heart: regular rate and rhythm, normal S1/S2 without gallop, murmur, click or rub;  Neurologic: DTR's 1+ B at patellar  Impression & Recommendations: Problem # 1:  MYALGIA (ICD-729.1)  Her updated medication list for this problem includes: Advil 200 Mg Tabs (Ibuprofen) ..... 1-2 by mouth with food or milk prn Hydrocodone-acetaminophen 5-325 Mg Tabs (Hydrocodone-acetaminophen) ..... 1-2 by mouth every 4-6 hours as needed for pain Cyclobenzaprine Hcl 10 Mg Tabs (Cyclobenzaprine hcl) ..... 1 by mouth 3 times a day as needed for muscle spasm or pain  Orders: CBC w/diff (CPT-85025), CMP (CPT-80053), Sed Rate (CPT-85651), CPK (CPT-82550), 99214 Detail (CPT-99214)  Patient Instructions: 1)  Return to clinic as needed. Precautions given regarding worsening or nonresolving symptoms. To ER if sig worse Prescriptions: HYDROCODONE-ACETAMINOPHEN 5-325 MG TABS (HYDROCODONE-ACETAMINOPHEN) 1-2 by mouth every 4-6 hours as needed for pain  #20 x 0
On August 29th, 2022, I tested positive for COVID-19. I called my doctor and they prescribe me Paxlovid.
blood clot formed in left arm; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient, not pregnant at time of vaccination, received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6198), via an unspecified route of administration, on right Arm on 27Feb2021 0100, SINGLE DOSE for covid-19 immunisation. Medical history included Diabetic, High blood pressure, both from an unknown date. Concomitant medications included glipizide, metformin, fenofibrate. The patient previously took sumatriptan succinate (IMITREX) and experienced drug allergy. After vaccination 6 days later (05Mar2021) a blood clot formed in left arm. Shot was given in right arm. Hospitalization followed and now on blood thinners. AE resulted in: Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event). The patient was hospitalized for 2 days. The outcome of the event was not recovered. Eliquis was given as treatment for the event. No covid prior vaccination. Not covid tested post vaccination.
Patient developed local reaction to injection with itching, localized erythema. Increased pain at injection site. Tingling of left upper extremity with certain arm movements, but this may be secondary to chronic injury. Appeared one day after injection. Itching mildly improved with diphenhydramine.
Pt was given pneumovax 23 in right arm. Pt called day after to report arm is red, swollen, pain and fever of 107. Told to apply lukewarm compresses and given Tylenol for pain.
Area of the injection site is swollen and warm to the touch; Spot of injection is red; Area of injection is swollen and warm to the touch; Soreness at the injection site; A spontaneous report was received from a 64-year-old, female consumer who received Moderna's COVID-19 vaccine and experienced soreness at the area of injection, spot of the injection is red, swollen and warm to the touch.   The patient's medical history was not provided. No relevant concomitant medications were reported.  On 28 Dec 2020 prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number:026L20A) intramuscularly for prophylaxis of COVID-19 infection.  On 28th Dec 2020, after receiving the vaccine, the patient experienced soreness at the vaccine site which resolved next day. On 3rd Jan 2021, day 7  after vaccination the  soreness at the vaccine site reoccurred with redness, swelling and warmth. She did not take any medications to alleviate the events.   Action taken with the second dose of mRNA-1273 in response to the event was not reported.  The outcome for the events was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
DEVELOPED FATIGUE, CHILLS, FEELING OF SOMETHING HEAVY ON CHEST, CONFUSION
Vaccine on 11/27/02. Starting next day, back aches (mid-back, below shoulders). Both sides, aches continued until today, 1 week later. Applied heat (heating pad), took Advil once, both gave temporary relief. Last two days, flu-like symptoms. No fever, no URI symptoms.
Started having symptoms on 5/30/22. Tested positive for COVID-19 on 6/1/22. I had a very sore throat, feverish, chills, body aches, headaches, congestion, nasal drip, phlegm, and a cough. The cough is productive. I am still dealing with these symptoms at this time.
local rxn @ inj site itching, redness, swelling & heat;5MAY PM advised application of heat by MD office;this was not done 6MAY AM start APAP & ice;
Twelve hours after vaccine, had severe immobilizing chills and cramping throughout body, that lasted about 45 minutes, couldn't stop shaking; After it subsided I was fine.
No other AE; Physician calling to report inadvertently administering an extra dose of MMR II to a 4 year old patient, one month after the second dose; This spontaneous report was received from a physician refers to a 4-year-old patient unknown gender. No information on patient's medical history, current conditions and concomitant medications was provided.      On 28-JUN-2023 the patient was vaccinated with extra dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) for prophylaxis (exact dose, dose number, route and site of administration, lot# and expiration date were not provided). Other suspect therapies included sterile diluent (STERILE DILUENT) for prophylaxis (extra dose administered and no adverse event).
I have had issues for the last years with bouts of sciatica that last a couple of weeks.  This episode has gone on now for  close to 3 months.  I have had extreme pain in my lower left back that goes into leg and foot.  This is typical with sciatica but this pain has been worse than I have ever had before and also my upper outer left thigh hurt so bad it was painful even to the touch.  I have never had that before.  The pain has moved around oddly  but always stayed on the left side.  I have been walking with a stick.  I have not had to do this before. I believe the inflammation flareup was due to the 2nd shot.
Patient felt dizziness after vaccine at about 5:25pm, but resolved by 5:55pm
This is in follow-up to report(s) previously submitted on 12/23/2008. Information has been received form a 69 year old female with no known allergies a history of body aches while on pravastatin who on 16-SEP-2008 was vaccinated with ZOSTAVAX (Merck) 0.65ml. Concomitant therapy included vitamins (unspecified), calcium (unspecified), fish oil and niacin. The patient reported that "5 days ago" on 25-SEP-2008 she experienced poison ivy on wrist after receiving ZOSTAVAX (Merck). Patient also stated that she was given a steroid shot (manufacturer unknown) on the 29-AUG-2008. The physician reported that on 07-SEP-2008, on exam she had hyperpigmentation and resolving papules consistent with a contact dermatitis. No lab diagnostics were performed. The patient's poison ivy persisted. The patient sought unspecified medical attention. Additional information is not expected.
Injection site swelling and localized itching started at about 11pm following vaccination at 6pm. The following day (Aug 9th), redness, swelling, and pain started to spread down the arm and up the neck to the ear. At this point, Patient called me and asked what to do. I advised her to take tylenol for the pain and benadryl for the local reaction.  I also advised use if an ice pack to calm to inflammation.  Nausea and vomiting occurred at around 5:30pm on the 9th. At this time, symptoms seem to be easing up, but she has been advised to rest, hydrate and monitor her symptoms. She will seek medical care if her symptoms worsen or persist despite OTC treatments over the next 12 hours.
Sore arm for 2 days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm for 2 days) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     Concomitant products included LOSARTAN, OMEPRAZOLE, ESCITALOPRAM OXALATE (LEXAPRO), CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), PROBIOTICS NOS and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced VACCINATION SITE PAIN (Sore arm for 2 days). On 02-May-2021, VACCINATION SITE PAIN (Sore arm for 2 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Breakthrough case admission after 3 vaccines Moderna 3/13/21 Lot# 040a21a;  Moderna 4/10/21 Lot# 038B21A;  Moderna 10/29/21 Lot# 058F21A
CORVOD19 VACCINE FEB 24, 2021 5:48 AM
Nauseated; Headache; This spontaneous case was reported by a consumer and describes the occurrence of (Nauseated) and (Headache) in an elderly female patient who received mRNA-1273  for COVID-19 prophylaxis.    Co-suspect product included non-company product (HUMIRA) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Intramuscular) 1 dosage form and (HUMIRA) (Subcutaneous) Citrate Free, Solution for injection in pre-filled syringe. On an unknown date, the patient experienced(Nauseated) and (Headache). At the time of the report,  (Nauseated) and  (Headache) had resolved.        The action taken with mRNA-1273 (Intramuscular) was unknown.       No concomitant medication was reported. On unknown dates, the patient experienced NAUSEATED and HEADACHE. On unknown dates, NAUSEATED and HEADACHE resolved.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  No treatment medication was reported.     This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Extreme Nausea  Diarrhea  Body Aches Chills Neck ache
Localized swelling and itching at injection site - 3"x5" - resolved fully in 3 days. Pt also had asthma symptoms. Pt used albuterol inhaler and took benadryl.
Pt experienced high fever, leg twitching and clumsiness. He was acting aggressively and continued to be clumsy for several weeks. He was treated by a naturopertric physician. (All info per pts mother)
On day 1 after vaccine (6/5), patient was exhausted/fatigued, had muscle pain and weakness, and had migraine/fever.  These severe symptoms only lasted for the day. Day 3 after vaccine (6/7), patient noticed they had a loss of taste and smell; everything smelled like rotten eggs or a gas leak, everything has an unpleasant taste except water. Patient noticed on day 4 (6/8) that he has a swollen, inflamed lymph node on the right inside of his mouth. Patient is still experiencing loss of taste and smell, and still experiencing swollen lymph node in mouth.
Tiredness; Chills; mild joint pain; Nausea; feeling unwell; he hasn't eaten; threw up; This is a spontaneous report from a contactable consumer (patient). A 28-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration by injection once in the left arm, near shoulder on 18Dec2020 at single dose for COVID-19 immunization.  Medical history included asthma from 2009 and ongoing (Has asthma but he has no breathing symptoms, no runny nose, no dry cough, no shortness of breath, no COVID symptoms).  There were no concomitant medications.  The patient experienced tiredness on 20Dec2020 with outcome of not recovered, chills on 20Dec2020 with outcome of recovered on 20Dec2020, mild joint pain on 20Dec2020 with outcome of recovered on 20Dec2020, nausea on 20Dec2020 with outcome of not recovered, feeling unwell on 20Dec2020 with outcome of not recovered, he hasn't eaten in Dec2020 with outcome of unknown, threw up in Dec2020 with outcome of unknown. No runny nose, cough or anything. Investigation Assessment: No. The patient took the COVID vaccine and was having mild symptoms, which he wished to report, and he was seeking recommendations. He had the print out thing given with all the symptoms that may happen, he had tiredness, chills, mild joint pain, nausea, and feeling unwell. He was a COVD tester, which is why he got it last week. This is not his first date of symptoms. Nausea: He threw up Sunday and Monday, was nauseous on Tuesday, is nauseous now but feels better, he missed work on Monday, he went for 2 hours yesterday and was sent home, he didn't go in today, but is feeling more normal, but has been perpetually nauseous since Sunday, like 24/7, in the middle of the night, middle of day, for no reason. He ate yesterday, he hasn't eaten today, because he feels nauseous. States feeling unwell goes along with nausea, he can't separate the two. What kind of medicine should he take, like over the counter or Pedialyte. What would a person potentially take if they were nauseous. Pedialyte, fluid or something. States this is Pfizer, he guesses any guidance is medical. Information on the Lot/batch number has been requested.
Excessive sleepiness, a lot of swelling and pain. Tingling and burning sensation on left side of breast. Arm was very sore to the point where she couldn't lift it.
Patient said he saw the vaccine liquid "squirt" out of his arm.  Patient was uncomfortable thinking that he may not have gotten the full dose.  Consulted CDC resources and decided to administer a second full dose in the opposite arm.
Whole right arm swollen 3 times the size, red, hot to the touch, and itchy. Fever of 104.5. Diagnosed with reaction and possible infection from vaccine shot.
stroke; shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation involving a 65 years old male patient (pt). There was no information about the pt's concurrent conditions, concomitant therapies or medical history provided. On an unknown day in February 2017, the pt was vaccinated with a dose of zoster vaccine live (ZOSTAVAX) (dosage regimen, route of administration, lot number and expiration date were not reported) at military clinic as prescribed and/or administered by a healthcare provider, for prevention of shingles and herpes Zoster related conditions. On 09-SEP-2019, the pt experienced shingles and a stroke (cerebrovascular accident), including any and all of its sequalae. It was reported that the pt would continue to suffer ongoing personal injuries, pain, suffering and emotional distress, as well as to incur substantial economic damages. The outcome of the events of shingles and cerebrovascular accident was not reported.   The reporter considered shingles and cerebrovascular accident to be related to Zoster Vaccine Live (ZOSTAVAX).  Upon internal review, the event of cerebrovascular accident was determined to be medically significant.
Patient developed a rash in  left armpit a week later. Came in to pharmacy and reported to pharmacist on duty started taking benadyrl. It was un relieved and  no developing a rash under right armpit. He stating the rash is now stating to burn.
4 hours after receiving booster dose of Moderna, pt reports feeling intense itching all over her body.  Denies any visible rash at this time.  Pt was seen by telehealth provider who prescribed Hydroxyzine HCl 25mg.  Pt has had previous reaction to Moderna dose 1 on 2/11/21, unclear if VAERs report was generated.  17 days after dose 1 (lot #024M20A ) pt had feeling of intense itching and  redness of left arm, with tingling all the way down to all of her fingers and extreme fatigue.
She was diagnosed with covid-19; She was diagnosed with covid-19; This is a spontaneous report from a contactable nurse and a contactable consumer (patient) via Pfizer-sponsored program.   A 41-year-old female patient (unknown if pregnant) received tofacitinib citrate (XELJANZ XR 11 mg; Expiration date: 28Feb2023), oral from 2019 to an unspecified date, at 11 mg, daily for Illness unspecified (as reported).  Patient also received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: unknown), via an unspecified route of administration, in Jan2021 at single dose for covid-19 immunisation .The patient medical history and concomitant medications were not reported. The patient previously took infliximab (REMICADE) and experienced allergy.  The patient was diagnosed with covid-19 on 05Aug2021. Patient stated she received monoclonal antibodies for treatment. The outcome of the event was not recovered.  The action taken in response to the event for tofacitinib citrate was unknown. The lot number for BNT162b2 was not provided and will be requested during follow up.; Sender's Comments: A causal relationship to the suspect drug BNT162B2 cannot be excluded for events drug ineffective and COVID-19 infection. A contributory role of tofacitinib cannot be fully excluded in the development of event COVID-19 based on its immunomodulatory properties. However, the temporal association is unclear based on the currently available information. Of note, there is an increased risk for  COVID-19 infection overall in light of the current pandemic. Event drug ineffective is related to BNT162B and is unrelated to tofacitinib. This case will be reassessed upon receipt of additional information.
Initial unsolicited report received from a nurse on 23 Jun 2017. This case involves a 72-year-old male patient who was vaccinated with a dose of FLUZONE QIV (Batch number: UI623AA, Expiry date: 30 Jun 2017, dose, and dose in series were not reported) via intramuscularly in the right deltoid on 20 Oct 2016. Patient's pre-existing physician diagnosed allergies, birth defects, medical conditions and concomitant medications were reported as none, and the patient had no illness at the time of vaccination. The patient concomitant medications were not reported. On 23 Oct 2016, three days after vaccination, the patient began to have loss of appetite, no taste in his mouth, headache, generalized weakness, fatigue and body aches. On an unknown date, after the vaccination, the patient also had lost 40 pounds. The patient relevant Laboratory investigations were not provided. Corrective treatment was not reported. The outcome of all the events were reported as not recovered. (Reported as Symptoms have lessened, but still remain). List of documents held by sender: none.
Patient came to ED with chest pain.  Had tested positive for covid 8/3/22 and was admitted with covid pneumonia 8/14 and treated with remdesivir.
Very dizzy; I felt an all over pressure in my whole body that made me feel like I was imploding; Felt drunk; felt very emotional; became exhausted/still tired; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 07Apr2021 12:00 (Lot number: ER8737) at the age of 55 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Connective tissue disorder" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DIZZINESS (non-serious) with onset 07Apr2021 12:00, outcome "not recovered", described as "Very dizzy"; DISCOMFORT (non-serious) with onset 07Apr2021 12:00, outcome "not recovered", described as "I felt an all over pressure in my whole body that made me feel like I was imploding"; FEELING DRUNK (non-serious) with onset 07Apr2021 12:00, outcome "not recovered", described as "Felt drunk"; EMOTIONAL DISORDER (non-serious) with onset 07Apr2021 12:00, outcome "not recovered", described as "felt very emotional"; FATIGUE (non-serious) with onset 07Apr2021 12:00, outcome "not recovered", described as "became exhausted/still tired". Therapeutic measures were not taken as a result of dizziness, discomfort, feeling drunk, emotional disorder, fatigue.  Additional information: Vaccine facilitated type was workplace clinic. The patient had not received any other vaccines within 4 weeks, had not received any other medications in two weeks, Within 2-3 minutes of receiving the vaccine the patient became very dizzy. Her son received his first dose at the same time and reported the same symptom to her. No Covid prior to vaccination and had not tested covid post vaccination, Known allergies was sensitivities but don't know to what, this is making it more clear however.  No follow-up attempts are possible. No further information is expected.
Began to feel achey, chills, headache and slight nausea. Symptoms persisted throughout the day and throughout the night. Symptoms resolved by the next day.
Flu shot was placed very high in left shoulder, not in muscle. At time of injection, pain was felt in left shoulder bone, left neck and behind left eye as injection was being placed. Pain continues in left shoulder with decreased range of motion.
Pale ant & post L neckfullness throat local pain nausea & vomit.
LIKE A SYNCOPE, EXCESSIVE SWEATING, PALE, FAINTED,LOW PRESSURE, NUMB FINGERS HANDS, VOMITS
Description: 22 y/o AD SM received primary SPV, typhoid, and Twinrix on 4 Dec 2007.  Noted the development of lymphadenopathy near the clavicle on 12/11 followed by erythema around the inoculation site migrating up the right neck and towards the axilla.  Patient also developed flu-like symptoms by 12/12/07.  Symptom: Lymphadenopathy, subclavicular.  Start: 12/11/2007.  Comment: Patient noted a lump around his clavicle.  Symptom: Flu-like symptoms <96 hours.  Start: 12/12/2007.  Comment: SM developed malaise, fatigue, aches in addition to his inoculation site concerns.  Symptom: Joint pain, isolated.  Start: 12/12/2007.  Comment: Bilateral knee pains reported during illness.
Headache, Myalgia, coughWheeze, Rash, 100.0 temp, nasal congestion, scratchy voice, chills Narrative: employee has taken benadryl prn for rash and tylenol prn for aches/low grade fever. Referred to PCP if sx worsen or  persist.  Other Relevant History:
Flu like symptoms on Day 5?sore throat, congestion, runny nose, headache, earache. No fever. Negative COVID test. Symptoms lasted 3 days.